Jane Street’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Jane Street’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-80,000	Closed	-$139K	–	6055
2018 Q2	$139K	Buy	+80,000	New	+$138K	﹤0.01%	4679
2018 Q1	–	Sell	-16,700	Closed	-$37K	–	5756
2017 Q4	$37K	Buy	16,700 +4,000	+31%	+$9.94K	﹤0.01%	4452
2017 Q3	$37K	Buy	+12,700	New	+$43.3K	﹤0.01%	4343

Other funds holding SGYP

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Jane Street's SGYP Position: Q1 2019 in Review

Jane Street sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 21,083 shares — an estimated $2K sold.

Jane Street first reported a position in SGYP in Q1 2014 and held it in 10 quarters. The position peaked at $636K in Q2 2015. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

Jane Street reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
Jane Street sold 21,083 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $2K.
Jane Street first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q1 2014 and held it in 10 quarters.
Jane Street's Synergy Pharmaceuticals, Inc Common Stock position peaked at $636K in Q2 2015.
12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.

Based on Jane Street's 13F filing for Q1 2019, filed 16 May 2019.